KeyBanc analyst Austin Wurschmidt raised the firm’s price target on American Healthcare REIT (AHR) to $55 from $43 and keeps an Overweight rating on the shares. The firm says fundamentals across the company’s ISHC and SHOP segments remain sound heading into 2026, with the demand funnel initially pointing to more muted seasonality in the near term and the portfolio positioned to capitalize on demographic tailwinds. American Healthcare REIT’s investment pipeline is also gaining momentum, while the balance sheet is on solid footing and cost of capital is improving.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AHR:
- American Healthcare REIT price target raised to $54 from $45 at RBC Capital
- American Healthcare REIT price target raised to $60 from $50 at Citizens JMP
- American Healthcare REIT Reports Robust Earnings Growth
- American Healthcare REIT, Inc. Reports Strong Q3 2025 Results
- American Healthcare REIT Reports Strong Q3 2025 Results